Lastly, IL-4R-targeted liposomal doxorubicin inhibited tumor growth more than chemotherapy in an orthotopic glioma xenograft model [144]

Lastly, IL-4R-targeted liposomal doxorubicin inhibited tumor growth more than chemotherapy in an orthotopic glioma xenograft model [144]

Lastly, IL-4R-targeted liposomal doxorubicin inhibited tumor growth more than chemotherapy in an orthotopic glioma xenograft model [144]. type 2 immune response. Similar to other ILCs, ILC2s are MRT-83 rapidly activated by signals deriving from tissue and/or other tissue-resident immune cells. The biologic activity of ILCs